Peijia Medical Limited (4WO) - Total Liabilities

Latest as of December 2025: €798.71 Million EUR ≈ $933.77 Million USD

Based on the latest financial reports, Peijia Medical Limited (4WO) has total liabilities worth €798.71 Million EUR (≈ $933.77 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Peijia Medical Limited liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Peijia Medical Limited - Total Liabilities Trend (2018–2025)

This chart illustrates how Peijia Medical Limited's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 4WO current and non-current assets.

Peijia Medical Limited Competitors by Total Liabilities

The table below lists competitors of Peijia Medical Limited ranked by their total liabilities.

Company Country Total Liabilities
Bank7 Corp
NASDAQ:BSVN
USA $1.69 Billion
Ningbo Tianyi Medical Appliance Co. Ltd.
SHE:301097
China CN¥1.16 Billion
Beijing InHand Networks Technology Co Ltd
SHG:688080
China CN¥231.99 Million
Guangdong New Grand Long Packing Co Ltd
SHE:002836
China CN¥164.48 Million
Yuanbao Inc. American Depositary Shares
NASDAQ:YB
USA $1.71 Billion
Nanjing Aolian Ae&Ea Co Ltd
SHE:300585
China CN¥218.44 Million
Nathans Famous Inc
NASDAQ:NATH
USA $71.95 Million
CIMB Thai Bank Public Company Limited
BK:CIMBT
Thailand ฿498.85 Billion

Liability Composition Analysis (2018–2025)

This chart breaks down Peijia Medical Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Peijia Medical Limited's balance sheet to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.21 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.43 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.30 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Peijia Medical Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Peijia Medical Limited (2018–2025)

The table below shows the annual total liabilities of Peijia Medical Limited from 2018 to 2025.

Year Total Liabilities Change
2025-12-31 €798.71 Million
≈ $933.77 Million
+24.00%
2024-12-31 €644.11 Million
≈ $753.03 Million
+61.88%
2023-12-31 €397.88 Million
≈ $465.17 Million
-41.39%
2022-12-31 €678.86 Million
≈ $793.66 Million
+369.85%
2021-12-31 €144.48 Million
≈ $168.92 Million
+112.49%
2020-12-31 €67.99 Million
≈ $79.49 Million
-95.27%
2019-12-31 €1.44 Billion
≈ $1.68 Billion
+435.05%
2018-12-31 €268.70 Million
≈ $314.14 Million
--

About Peijia Medical Limited

F:4WO Germany Medical Devices
Market Cap
$403.11 Million
€344.80 Million EUR
Market Cap Rank
#13493 Global
#1396 in Germany
Share Price
€0.52
Change (1 day)
-0.96%
52-Week Range
€0.39 - €0.78
All Time High
€3.90
About

Peijia Medical Limited, together with its subsidiaries, engages in the research, development, manufacturing, and sales of transcatheter valve therapeutic and neurointerventional procedural medical devices in the People's Republic of China. It operates through Transcatheter Valve Therapeutic Business, Neurointerventional Business, and Future Technology Business segments. The company's products inc… Read more